Formation Bio Acquires Rights to Innovative Autoimmune Treatment from CTFH Formation Bio expands its portfolio with the acquisition of an innovative oral treatment for autoimmune diseases, enhancing patient care options.

Formation Bio Acquires Rights to Innovative Autoimmune Treatment from CTFH #USA #New_York #Formation_Bio #miR-124 #CTFH